Glaucoma Awareness

Redesigned probe for micropulse transscleral laser therapy for glaucoma proves less is more

The lower energy applications and slower sweep speeds offer marked IOP reductions in patients.

Researchers discover glaucoma and chronic kidney disease have more in common than what meets the eye

A team of investigators from the Yong Loo Lin School of Medicine at the National University of Singapore has found that there is a bidirectional association between chronic kidney disease and glaucoma.

Australian scientists conduct stem cell research unveiling a detailed genetic roadmap of glaucoma

The research is the result of a national collaboration led by investigators from the Centre for Eye Research Australia at the University of Melbourne and University of Tasmania and the Garvan Institute of Medical Research.

iSTAR Medical unveils positive results for MINIject across trio of international glaucoma trials

June 11, 2022

According to the company, no safety concerns with corneal endothelial health reported across all 3 trials, and the device delivered consistent results up to two-year follow-up in patients across Central and South America, Asia and Europe.

Research to Prevent Blindness, Aerie teaming up to offer glaucoma research grant

May 17, 2022

Two grants will be available, each offering $150,000 to scientists focusing on glaucoma research who have already received their first independent federal National Institutes of Health (NIH) grant and are collecting new and novel data to apply for a second R01.

Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucoma

March 08, 2022

A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.

Study: Minorities with glaucoma facing cost barriers to medication

March 04, 2022

In advance of World Glaucoma Week March 6-12, a study of 3826 patients with glaucoma has found significantly higher odds of self-reported difficulty affording medication observed among non-Hispanic African American and Hispanic individuals compared with non-Hispanic White individuals.